from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2262c/-

LFCtreatmentdescriptionclass of inhibitor

-0.649

Amikacinug/mL Amikacintranslation

-0.039

Cap5-10ug/mL Capreomycintranslation

0.799

Rox10-50 ug/mL Roxithromycintranslation

-0.225

SM2-5 ug/mL Streptomycintranslation

-1.816

Tet5-10 ug/mL Tetracyclinetranslation

0.287

Rif0.2-5ug/mL Rifampicintranscription

0.789

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.206

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.526

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.933

CPZ10-50 ug/mL Chlorpromazinerespiration

0.470

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.005

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.616

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.199

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.292

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.597

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.121

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.727

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.294

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.094

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.738

KCN5-20 ug/mL Potassium cyaniderespiration

0.595

NaN30.2-2 mM Sodium aziderespiration

-0.170

Nigericin50 uM Nigericinrespiration

0.406

TRC10-150 ug/mL Triclosanrespiration

0.906

TRZ10-25 ug/mL Thioridazinerespiration

-0.261

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.844

menadione6-10 ug/mL Menadionerespiration

0.515

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.133

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.067

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.278

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

2.959

NRP_1Non-replicating persistence stage 1dosRassociated

0.128

Amp0.2mg/mL AmpicillincellWall

0.150

Cephalexin20-100 ug/mL CephalexincellWall

0.573

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.396

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.329

EMB10-20 ug/mL EthambutolcellWall

0.153

Eta12-40 ug/mL EthionamidecellWall

-0.396

INH0.2-0.4 ug/mL IsoniazidcellWall

0.830

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.112

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.607

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.646

BZA0.12 mg/mL BenzamidearomaticAmides

-0.524

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.550

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.243

H2O24 mM hydrogen peroxideDNAdamaging

0.691

Levo10 ug/mL LevofloxacinDNAdamaging

-0.391

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.814

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.514

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.636

UVUV-irradiationDNAdamaging

1.596

ARP41-4 ug/mL Antitubercular compound ARP4?

0.064

Antimycin12.5-50 ug/mL Antimycin A?

-0.328

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.027

PA_110-50 ug/mL Antitubercular compound PA-1?

0.079

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.125

PA8240.2-2 ug/mL PA-824?

-0.719

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.608

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.192

Verapamil50 uM Verapamil?

-0.269

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.415

methoxatin10-20 ug/mL Methoxatin?